These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32767710)

  • 41. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
    Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis.
    Wild RA; Rizzo M; Clifton S; Carmina E
    Fertil Steril; 2011 Mar; 95(3):1073-9.e1-11. PubMed ID: 21247558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls.
    Huddleston HG; Quinn MM; Kao CN; Lenhart N; Rosen MP; Cedars MI
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):775-782. PubMed ID: 29044581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.
    Mather KJ; Kwan F; Corenblum B
    Fertil Steril; 2000 Jan; 73(1):150-6. PubMed ID: 10632431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
    Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?
    Shema-Didi L; Kristal B; Sela S; Geron R; Ore L
    Nutr J; 2014 Mar; 13():18. PubMed ID: 24593225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.
    Cenk Sayin N; Gücer F; Balkanli-Kaplan P; Ali Yüce M; Yardim T
    Gynecol Endocrinol; 2003 Oct; 17(5):387-96. PubMed ID: 14710586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.
    Yarali H; Yildirir A; Aybar F; Kabakçi G; Bükülmez O; Akgül E; Oto A
    Fertil Steril; 2001 Sep; 76(3):511-6. PubMed ID: 11532474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Egg Consumption on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rouhani MH; Rashidi-Pourfard N; Salehi-Abargouei A; Karimi M; Haghighatdoost F
    J Am Coll Nutr; 2018 Feb; 37(2):99-110. PubMed ID: 29111915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipid and lipoprotein profile in women with polycystic ovary syndrome.
    Macut D; Panidis D; Glisić B; Spanos N; Petakov M; Bjekić J; Stanojlović O; Rousso D; Kourtis A; Bozić I; Damjanović S
    Can J Physiol Pharmacol; 2008 Apr; 86(4):199-204. PubMed ID: 18418429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dyslipidemia and oxidative stress in PCOS.
    Macut D; Bjekić-Macut J; Savić-Radojević A
    Front Horm Res; 2013; 40():51-63. PubMed ID: 24002405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome.
    von Eckardstein S; von Eckardstein A; Bender HG; Schulte H; Assmann G
    Gynecol Endocrinol; 1996 Oct; 10(5):311-8. PubMed ID: 8915660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of Dyslipidaemia and Pre-Diabetes Among Women with Polycystic Ovary Syndrome (PCOS): Do We Overestimate Cardiovascular Risk?
    Lewandowski KC; Płusajska J; Horzelski W; Lewiński A
    Horm Metab Res; 2019 Aug; 51(8):539-545. PubMed ID: 31075796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.